ABOUT THE PROGRAM
Positioning promising biomedical technologies to address UNDER SERVED healthcare needs
The Columbia Biomedical Engineering Technology Accelerator (formerly the Columbia-Coulter Translational Research Partnership) aims to catalyze the advancement of biomedical technologies by providing funding, education, resources and mentorship to teams of clinicians, engineers and scientists working to develop solutions to clinical unmet needs, with the ultimate goal of bringing innovative research out of the lab to benefit society.
Project support is expected to serve as a bridge to commercial investment, with awards granted to perform specific tasks needed to validate a commercial hypothesis (vs. a scientific hypothesis). Regardless, award recipients are encouraged to submit their funded research outcomes for publication in academic journals.
Funding for the program has been generously provided by the Dept of Biomedical Engineering at the Fu Foundation School of Engineering and Applied Science, the Depts of Surgery, Orthopedic Surgery and Radiology at Columbia University Medical Center, and Columbia Technology Ventures, the technology transfer office of Columbia University.
In addition, BiomedX is sponsored by Columbia’s School of Engineering, Yiannis and Jamie Monovoukas, the Department of Medicine, the College of Dental Medicine, the Division of Cardiology, the Irving Institute for Clinical and Translational Research, and the Vagelos College of Physicians and Surgeons.
FUNDING
Funding is available to support selected projects and in-kind additional resources (marketing, regulatory, reimbursement, and legal).
MENTORSHIP
Selected teams are connected with experts in regulatory strategy, intellectual property counsel, reimbursement, marketing identifying and product development.
PROJECT MANAGEMENT
Funded project teams work with a commercialization team as active partners, and meet regularly with Program Management to review technical and business milestones.
